It is a unique company since it develops a comprehensive solution for the problems associated with breast cancer.

Our products in development, based on positive proofs of concept in animal models, achieve:

– Increased immune response of the patient, which is specified in a higher cure rate and significant reduction in the appearance of metastases.

– Reduction of damage to organs and deep tissue of the breast associated with radiotherapy.

– Reduction of superficial tissue damage (epidermis, dermis and nerve endings) associated with radiotherapy treatment and mastectomy surgical procedures.

Thanks to this comprehensive solution, action is taken both at the level of antitumor treatment and in the protection of internal organs (heart and lungs) and in the preservation of breast tissue, with a view to maintaining healthy tissue, subsequent breast reconstruction and maintenance of sensitivity breast erogenous.

Disit Biotech is particularly proud to collaborate with the Pink Knot Project, a global initiative that aims to impact in the universe of breast cancer.